Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants Jul 19, 2023 | Uncategorized
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting Jul 19, 2023 | Uncategorized
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells Jul 7, 2023 | Uncategorized
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) Jul 7, 2023 | Prostate
